Okay, let's start by understanding the question. The user is asking about which test is prolonged in hemorrhagic disease of the newborn. I remember that hemorrhagic disease of the newborn, also known as vitamin K deficiency bleeding (VKDB), is related to a deficiency in vitamin K. Vitamin K is crucial for the synthesis of clotting factors.

So, the clotting factors affected are II, VII, IX, and X. These are the vitamin K-dependent clotting factors. The question is about which lab test would show a prolongation. The prothrombin time (PT) measures factors I, II, V, VII, X, and fibrinogen. Since VII is one of the factors affected and has a short half-life, PT is usually the first to be prolonged. Partial thromboplastin time (PTT) includes factors that are also vitamin K-dependent, like X, but maybe PTT isn't as sensitive here.

Now, looking at the options, even though the options aren't listed, common distractors in such questions might include PT, PTT, INR, or maybe even thrombin time. The correct answer should be PT because of the quick response to vitamin K deficiency affecting factor VII. PTT could be prolonged if other factors are involved, but in early deficiency, PT is more likely to show changes first.

Wait, but if the question is about hemorrhagic disease of the newborn, which is typically due to vitamin K deficiency, the main issue is the lack of vitamin K leading to undercarboxylation of these factors. So, PT would be prolonged because factor VII is affected. PTT might be normal unless other factors are involved. So the core concept here is the vitamin K-dependent factors and which tests they affect. The correct answer is PT. The incorrect options would be other tests like PTT, INR (which is a calculated value from PT), or maybe thrombin time which is more about fibrinogen and thrombin.

Clinical pearl: Remember that in VKDB, PT is the most sensitive test initially because factor VII has a short half-life, so it drops quickly. The clinical pearl is to associate vitamin K deficiency with PT prolongation. Also, administering vitamin K is the treatment. So the explanation needs to highlight why PT is prolonged and why other tests aren't.

**Core Concept**
Hemorrhagic disease of the newborn (HDN) is caused by vitamin K deficiency, leading to impaired synthesis of vitamin K-dependent clotting factors (II, VII, IX, X). Prothrombin time (PT) is the key test to assess extrinsic coagulation pathway, primarily reflecting factor VII levels.

**Why the Correct Answer is Right**
Prothrombin time (PT) is prolonged in HDN because factor VII has the shortest half-life (~4–6 hours) among vitamin K-dependent factors. Deficiency manifests earliest as PT prolongation. Vitamin K administration rapidly corrects this deficiency by enabling γ-carboxylation of clotting factors, restoring their activity.

**Why Each Wrong Option is Incorrect**
**Option A:** Partial thromboplastin time (PTT) is less sensitive in early HDN since it primarily reflects intrinsic pathway factors (VIII, IX, XI, XII).
**Option B:** Activated partial thromboplastin time (aPTT) may remain normal unless severe deficiency affects factors IX or XI.

✓ Correct Answer: B. aPTT